Baird's 2024 Global Healthcare Conference
Logotype for Align Technology Inc

Align Technology (ALGN) Baird's 2024 Global Healthcare Conference summary

Event summary combining transcript, slides, and related documents.

Logotype for Align Technology Inc

Baird's 2024 Global Healthcare Conference summary

21 Jan, 2026

Market environment and growth outlook

  • Global orthodontics market remains stable, with regional variations tied to inflation and interest rates; Southeast Asia, Latin America, and the Middle East are performing better than others.

  • Teen segment is less discretionary and offers significant growth potential, as only 30% of cases are teens versus 75% in the general market.

  • Adult market growth is expected to be slower than teens but should outpace the overall industry once macroeconomic conditions improve.

  • There are 500-600 million potential adult patients with malocclusion, indicating long-term demand.

  • Teen market is projected to grow at double-digit rates when macro conditions normalize.

Product innovation and adoption

  • Invisalign Palatal Expander (IPE) targets 15-20% of teen cases, with initial adoption in North America and ANZ; expansion to more countries is planned.

  • IPE is priced at $500, offering flexibility and technological advantages over traditional metal devices.

  • The palatal expansion market is estimated at $1.5 billion, with expectations to capture 10-20% share in the next few years.

  • Doctors are seeking combined solutions (phase one and two) for skeletal expansion and teeth straightening.

  • New iTero Lumina scanner with NIRI technology is approved and positioned for further growth in both ortho and restorative markets.

Pricing, ASP trends, and financial strategies

  • Global ASP declined just over 5% year-over-year, with $22 of the $40 drop due to currency and $8 due to UK VAT changes.

  • Remaining ASP pressure is attributed to increased sales to new submitters and lower-stage cases, which are gross margin accretive.

  • ASP is expected to remain flat to slightly down, consistent with historical trends.

  • Doctor Subscription Program (DSP) has grown from 1% to 4% of case volume, with potential for further growth as it expands internationally.

  • DSP and leasing models for iTero scanners help doctors manage cash flow and are gross margin accretive, supporting broader adoption.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more